MedTrace Logo

The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China

NCT04857086 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2021-04-23

No results posted yet for this study

Summary

* To find out the gap between real-world clinical practice and guideline recommendations in initial management of DTC patients
* To observe the characteristics of patients who achieved and did not achieve TSH target value after five year follow-up
* To assess response to initial therapy in patients who undergo total or neartotal thyroidectomy and RAI remnant ablation after five year follow-up (according to an modified dynamic risk stratification system)
* To observe the recurrence status after five year follow-up

Conditions

  • Differentiated Thyroid Cancer

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • First Affiliated Hospital of Kunming Medical University

    collaborator OTHER

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • China-Japan Union Hospital, Jilin University

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Tongji Hospital

    collaborator OTHER

  • First Hospital of China Medical University

    collaborator OTHER

  • Gansu Cancer Hospital

    collaborator OTHER

  • Huazhong University of Science and Technology

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-30
Primary Completion
2022-07-30
Completion
2023-03-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04857086 on ClinicalTrials.gov